Search

everythinglearnresearchcommunity

for

Search:↓

Videodermoscopy better identifies female hair loss than clinical diagnosis.

The document concludes that molluscum contagiosum is a common, benign skin infection in children, often healing without scarring.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

Lupus can cause hair loss and nail changes, with treatments available for both.

A man developed a rare scalp disorder, Folliculitis Decalvans, 20 years after hair restoration surgery, and it required long-term antibiotic treatment.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

Careful planning and accurate diagnosis are crucial for successful hair restoration surgery.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Most hair loss in captive rhesus macaques is likely due to environmental and behavioral factors.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Trichoblastomas in rabbits are linked to uncontrolled embryonic hair growth and have distinct histological features.

Elderly men with a scalp condition healed in about 26 days using specific creams and dressings, with no return of the condition in 6 months.